Gilead has 15 products on the market.
| Brand Name | Drug Name(s) | Indication | Date Approved (USA) | Marketing Partner(s) | U.S. Patent Expiration | European Patent Expiration |
|---|---|---|---|---|---|---|
| AmBisome | liposomal amphotericin B | fungal infection, cryptococcal meningitis, Aspergillus, Candida, Cryptococcus infections | 1997-08-11 | Astellas Pharma(USA)Rapiscan(EU) | 2016 | 2008 |
| Atripla | tenofovir, emtricitabine, and efavirenz | HIV, AIDS | 2006-07-12 | Bristol-Myers Squibb | 2021 | 2018 |
| Cayston | Aztreonam | Cystic Fibrosis | 2010-02-22 | 2021 | 2021 | |
| Complera | tenofovir, emtricitabine, and rilpivirine | HIV, AIDS | 2011-08-10 | Johnson and Johnson | ||
| Emtriva | emtricitabine | HIV, AIDS | 2003-07-02 | 2021 | 2016 | |
| Flolan | epoprostenol sodium | pulmonary hypertension | 1995-09-20 | GlaxoSmithKline | expired | expired |
| Hepsera | adefovir dipivoxil | hepatitis B (HBV) | 2002-09-20 | 2014 | 2011 | |
| Letairis | ambrisentan | Pulmonary arterial hypertension | 2007-06-15 | GlaxoSmithKline | 2015 | 2015 |
| Lexiscan | regadenoson | myocardial perfusion imaging | 2008-04-10 | Astellas | 2019 | 2020 |
| Macugen | pegaptanib sodium solution | age-related macular degeneration | 2004-12-17 | OSI and Pfizer | 2017 | 2017 |
| Ranexa | ranolazine | angina | 2006-01-27 | Hoffmann–La Roche | 2019 | 2019 |
| Stribild | elvitegravir, cobicistat, emtricitabine, tenofovir | HIV, AIDS | 2012-08-27 | |||
| Tamiflu | oseltamivir phosphate | influenza | 1999-10-27 | Hoffmann–La Roche | 2016 | 2016 |
| Truvada | emtricitabine and tenofovir | HIV, AIDS | 2004-08-02 | 2021 | 2018 | |
| Viread | tenofovir | HIV, AIDS, hepatitis B | 2001-10-26 | 2017 | 2018 | |
| Vistide | cidofovir | CMV retinitis | 1996-06-26 | Pfizer | 2010 | 2012 |
Read more about this topic: Gilead Sciences
Famous quotes containing the word product:
“Out of the thousand writers huffing and puffing through movieland there are scarcely fifty men and women of wit or talent. The rest of the fraternity is deadwood. Yet, in a curious way, there is not much difference between the product of a good writer and a bad one. They both have to toe the same mark.”
—Ben Hecht (1893–1964)